The purpose of this newly formed professional organization is to improve neuroendocrine tumor (NET) disease management through increased research and educational opportunities.

  2009 Conference Details 
Charlotte, North Carolina - Oct 2 & 3, 2009
 

When NET diseases have advanced, what treatments are most effective? Experts in the field are continually improving treatment strategies and developing new approaches to symptom control.


NANETS Perspective on Angiogenesis Inhibitors

  NET Task Force Statement on VEGF Pathway Inhibitors

 

To deliver the highest quality care to patients with neuroendocrine tumors, an interdisciplinary approach to disease management is important. NANETS members are available to answer your questions and help you develop these collaborative partnerships.

Levels for Corporate Liaison Committee

Developing the next generation of clinicians and researchers in the field of NET diseases is an important objective of the NANETS organization. A variety of educational opportunities are available.


NEW: 2009 Young Investigator Award Recipient